Compatibility assessment of a temperature-controlled radiofrequency catheter with a novel electroanatomical mapping system.

Background: The novel DiamondTemp ablation system (DTA) and EnSiteX mapping System (EAM) are both CE-Marked and FDA approved medical devices. The DTA has been validated by its manufacturer only in combination with previous version of EnSite System-EnSite Precision. The aim of this study was to evaluate compatibility of DTA with EnSite X with a previously developed protocol.